Skip to content

New chairman Kenneth Nyblom about e-VIS and the future

Pressbild FGL

On a day-to-day basis, Kenneth Nyblom is the CEO of FGL (The Association for Generic Medicines and Biosimilars). Recently he was also appointed chairman of the board at e-VIS and as such will lead the organisation’s operations. But he is not new to the context, but has been involved since the planning phase.

Full interview in Swedish

Publicity photo: FGL